Selected inhibitors of protein tyrosine kinase activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8455484
APP PUB NO 20110257175A1
SERIAL NO

13082944

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides new compounds and compositions thereof. The invention also provides methods for treating ophthalmic diseases, disorders and conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • METHYLGENE, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Claridge, Stephen William Montreal, CA 22 275
Gaudette, Frédéric Sherbrooke, CA 6 46
Raeppel, Franck Montreal, CA 22 124
Raeppel, Stéphane St. Lazare, CA 10 72
Vaisburg, Arkadii Kirkland, CA 56 936
Zhan, Lijie Montreal, CA 21 255

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 4, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00